课题基金 / 基金详情

NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS

NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
NNK 对肺细胞受体通路的影响
批准号:
2094195
负责人:
Hildegard M. Schuller
金额:
$19.12万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 1996-12-31

项目摘要

项目成果

Hildegard M. Schuller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Neuroendocrine cancer and peripheral adenocarcinoma are the most common histological lung cancer types linked with smoking. The nicotine-derived nitrosamine, 4-(methylnitrosamino)-1-(2-pyridyl)-1- butanone (NNK) is among the most abundant and potent carcinogens contained in cigarette smoke. NNK induces a high incidence of peripheral adenocarcinomas in the lungs of laboratory rodents maintained under ambient air conditions while it causes lung cancers of neuroendocrine differentiation when administered to hyperoxic hamsters. Having shown that NNK binds to nicotinic cholinergic and beta-adrenergic receptors in hamster lung and lung cancer cell lines Dr. Schuller proposes to study the effects of NNK on mitogenic signal transduction pathways stimulated by these receptor types. Specific Aim Having shown that NNK-induced mitogenesis of cell lines derived from peripheral pulmonary adenocarcinomas involves binding to beta adrenergic receptors (b-AR) and activation of cyclic AMP, Dr. Schuller will study the acute and chronic effects of NNK on this signal transduction pathway in vitro using normal and NNK transformed human bronchial cells and normal hamster Clara cells as well as cell lines derived from human and hamster lung adenocarcinomas as model systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    8064258
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
Modulation of cancer prevention by social stress
  • 批准号:
    7809021
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    8252196
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    7714157
  • 项目类别:
  • 资助金额:
    $27.27万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
海外基金